News

Latanoprost Ophthalmic Solution, 0.005% is the generic version of Pharmacia and Upjohn’s Xalatan Ophthalmic Solution, an eyedrop that lowers pressure in the eye. Latanoprost reduces pressure in the

Besides, a product portfolio of over 100 research-based ELISA kits that cover research categories such as angiogenesis, apoptosis, endocrinology, immunology, inflammation, oncology and signal transduction will also be

Prior to joining Depomed, Schoeneck worked as the CEO of BrainCells, a biopharmaceutical company in San Diego, California. Before BrainCells, Schoeneck was the president and CEO of a

Romaco develops customer solutions for various forms of drug packaging and delivery systems and complex processing applications. DBAG Board of Management member Rolf Scheffell said in partnering with

The three new grants, combined with other grants renewed for 2011, brings total non dilutive R&D funding for 2011 to $4.8m, with an additional $3.3m committed for future

Currently, Lanxess is supplying specialty chemicals, color pigments to the Middle East customers for the construction industry and high-tech plastics and rubbers. The company has named Elie Saad

RE-LY is a PROBE (prospective, randomised, open-label with blinded endpoint evaluation), designed to compare two fixed doses of the oral direct thrombin inhibitor dabigatran (110mg and 150mg bid)

Sertech prepares patient instructional leaflets for its US pharmaceutical customers. The acquired company will immediately change its trading name to CCL Label. CCL Label manufactures similar products at

The ABSORB trial is a prospective, non-randomized (open label), two-phase study that recruited 131 patients from Australia, Belgium, Denmark, France, the Netherlands, New Zealand, Poland and Switzerland. Key